Read the latest issue of Impact, the University of Chicago Celiac Disease Center’s newsletter here. This issue's feature article covers celiac disease and brain fog. There is also a review of the recent small study looking at cross contact as well as a summary from the symposium including research updates.
The SCOPE Boston interviewed the Director of our Gluten-Free Food Bank for this article titled, For the food insecure, dietary restrictions pose an additional challenge.
The Washington Post printed this article about how to use gluten-free flours when baking.
This article discusses the Oral Impact of Celiac Disease.
Anokion announced that they received FDA clearance for KAN-101, an investigational new drug to treat celiac disease.
Takeda's phase 2 trial of TAK-101 is reported to show promise as a potential treatment.
Listen to this BBC broadcast titled, Why is Wheat Making People Sick?